Genmab A/S Dkk

(GNMSF)

By |

Profile

Genmab A/S is an antibody company focused on cancer. Its first marketed product is Arzerra (ofatumumab); development pipeline incl. daratumumab and two proprietary technology platforms; DuoBody (bispecifics) & HexaBody (effector function enhancement).

Contact Information

Website: www.genmab.com
Main Phone: +45 70202728
Address: Bredgade 34E
City / Town: Copenhagen K
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: GREY
Employees: 189
$ 168.00 $ 0.00 (0.00%)
Last Price 168.00 Change $ 0.00 Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 168.00
Last Trade Volume 0 52 Wk Hi 183.00 52 Wk Low 94.74
Market Cap 10.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 60,148,597.00 EPS (TTM) 1.75 PE Ratio 95.90 Exchange Greys
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 51.98 51.98 51.98 13.68
Low Target Price Estimate 51.98 51.98 51.98 13.68
Mean Target Price Estimate 51.98 51.98 51.98 13.68
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/23/07 08/23/07 08/23/07 04/28/10
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1